Proceedings
Author : United States. Food and Drug Administration
Publisher :
Page : 0 pages
File Size : 35,39 MB
Release : 1963
Category : Drugs
ISBN :
Author : United States. Food and Drug Administration
Publisher :
Page : 0 pages
File Size : 35,39 MB
Release : 1963
Category : Drugs
ISBN :
Author : National Library of Medicine (U.S.)
Publisher :
Page : 910 pages
File Size : 18,66 MB
Release : 1960
Category : Medicine
ISBN :
Author :
Publisher :
Page : 1068 pages
File Size : 11,97 MB
Release : 1979
Category : Cosmetics
ISBN :
Author :
Publisher :
Page : 1068 pages
File Size : 24,18 MB
Release : 1979
Category : Cosmetics
ISBN :
Author : United States. Food and Drug Administration
Publisher :
Page : 92 pages
File Size : 42,1 MB
Release : 1963
Category : Drugs
ISBN :
Author : United States. Superintendent of Documents
Publisher :
Page : 792 pages
File Size : 24,12 MB
Release : 1963
Category : Government publications
ISBN :
Author : Stephen Skowronek
Publisher : University of Pennsylvania Press
Page : 460 pages
File Size : 24,71 MB
Release : 2008-08-20
Category : History
ISBN : 9780812219906
Seventeen essays illuminate critical junctures in American political development—from the social movements for women's suffrage, civil rights, and workers' rights, to Reconstruction, to the regulation of prescription drugs—as vantage points from which to examine how change is enacted.
Author : United States. Congress. House. Committee on Government Operations
Publisher :
Page : 1600 pages
File Size : 17,45 MB
Release : 1964
Category : Drugs
ISBN :
Author : Daniel Carpenter
Publisher : Princeton University Press
Page : 825 pages
File Size : 33,34 MB
Release : 2014-04-24
Category : Political Science
ISBN : 1400835119
How the FDA became the world's most powerful regulatory agency The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuticals while resisting efforts to curb its own authority. Carpenter explains how the FDA's reputation and power have played out among committees in Congress, and with drug companies, advocacy groups, the media, research hospitals and universities, and governments in Europe and India. He shows how FDA regulatory power has influenced the way that business, medicine, and science are conducted in the United States and worldwide. Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA's waning influence in drug regulation today. Reputation and Power demonstrates how reputation shapes the power and behavior of government agencies, and sheds new light on how that power is used and contested. Some images inside the book are unavailable due to digital copyright restrictions.
Author : United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee
Publisher :
Page : 2438 pages
File Size : 31,47 MB
Release : 1964
Category : Drugs
ISBN :
Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5.